We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function

This study is currently recruiting participants.
Verified November 2016 by Yves Beguin, University Hospital of Liege
Sponsor:
ClinicalTrials.gov Identifier:
NCT00603330
First Posted: January 29, 2008
Last Update Posted: November 9, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborators:
Katholieke Universiteit Leuven
Maastricht University Medical Center
Ziekenhuis Netwerk Antwerpen (ZNA)
University Hospital, Antwerp
University Hospital, Ghent
AZ-VUB
AZ Sint-Jan AV
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
University Hospital of Mont-Godinne
Jolimont Hospital Haine Saint Paul
Queen Fabiola Children's University Hospital
Information provided by (Responsible Party):
Yves Beguin, University Hospital of Liege
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2019
  Estimated Primary Completion Date: December 2018 (Final data collection date for primary outcome measure)